This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Banks Deliver and the Rally Continues
by David Borun
After an encouraging start to earnings season, stocks continue to rise.
What's in the Store for UnitedHealth (UNH) Earnings in Q1?
by Zacks Equity Research
UnitedHealth (UNH) should gain from higher revenues, membership partly offset by rise in expenses.
Dow 30 Stock Roundup: Procter & Gamble Hikes Dividend, Boeing Q1 Commercial Deliveries Fall
by Swarup Gupta
The index traversed a lackluster trading week as investors looked toward first-quarter earnings numbers for direction.
Healthcare Stocks in Focus on Regulatory and Political Risk
by Sapna Bagaria
Healthcare stocks suffered declines in the Medicare-for-All policy and revving up of drug price rebate.
What's in Store for Dow ETF in Q1 Earnings?
by Sweta Killa
Let's delve into the Q1 earnings picture that will likely set up the movement of the Dow Jones ETF in the coming days.
UnitedHealth's (UNH) Unit to Upgrade Care Bundles Program
by Zacks Equity Research
UnitedHealth's (UNH) arm to offer better care with its enhanced UnitedHealthcare Care Bundles Program.
Bull of the Day: Centene (CNC)
by Kevin Cook
Instead of being acquired by managed care giants, CNC goes on the offensive in $17.3 billion bid for WCG
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $248.79 in the latest trading session, marking a +0.02% move from the prior day.
UnitedHealth Group (UNH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval
by Swarup Gupta
The index notched up another week of gains riding on optimism over the increasing likelihood of a U.S.-China trade deal.
UnitedHealth Group (UNH) Stock Moves -0.46%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $244.41, moving -0.46% from the previous trading session.
2020 Medicare Rate Exceeds Proposal, Health Insurers to Gain
by Sapna Bagaria
A higher rate of Medicare Advantage reimbursement will benefit health insurers having exposure to this business.
Bull of the Day: Pegasystems (PEGA)
by Kevin Cook
New marketing strategy to reveal this CRM competitor has been building top BPM software for 35 years
Stock Market News For Apr 1, 2019
by Zacks Equity Research
Markets closed in the green on Friday, the last trading day of the first quarter of 2019.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $241.47, moving -0.79% from the previous trading session.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $252.02 in the latest trading session, marking a +0.61% move from the prior day.
WellCare Health Arm MeridianRx Unveils Mobile Application
by Zacks Equity Research
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
Universal Health's Acute Care Segment Solid, High Debt Ails
by Zacks Equity Research
Riding high on solid segmental performances, Universal Health (UHS) promises to reap great benefits for investors. However, its debt load bothers.
HCA Healthcare to Buy Large Stake in Galen College of Nursing
by Zacks Equity Research
HCA Healthcare (HCA) to purchase the majority interest in Galen College of Nursing for boosting access to nursing education.
Humana, Accolade to Team Up for Providing Advanced Healthcare
by Zacks Equity Research
Humana (HUM) ties up with Accolade to meet healthcare needs of employers and their health plan members.
Why is it Worth Keeping Humana (HUM) in Your Portfolio Now?
by Zacks Equity Research
Riding high on robust Medicare business and strategic buyouts, Humana (HUM) looks promising to reap benefits for investors.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $253.45, moving +0.48% from the previous trading session.
Stock Market News For Mar 14, 2019
by Zacks Equity Research
U.S. stocks closed sharply higher on Wednesday following the release of strong economic data.
4 HMO Q4 Outperformers Likely to Retain Beat Streak in Q1
by Srijita Guha
Based on a few key factors, we zero in on four HMO stocks that are set to retain the bull run in first-quarter 2019.
Here's Why You Should Add Tenet Healthcare to Your Portfolio
by Zacks Equity Research
Riding high on a solid inorganic growth profile and divestitures, Tenet Healthcare (THC) holds ample chances of reaping benefits for investors.